A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body. These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.
Immunizations and Autoimmune Disease
What is safe and what to avoid in this patient population
No Clear Connection Between Inflammation & Disease Progression in AS
TNF blockers decrease symptoms but seem to have little impact on structural damage
Research on IL-17 Cytokine May Lead to Novel Therapies for RA
Research in the laboratory of John D. Mountz, MD, PhD, is opening up a whole new field of study in rheumatoid arthritis (RA).
Are We Playing It Safe?
Tumor necrosis factor alpha inhibition and the risk of solid malignancies
Unique Meeting Accelerates RA Research
More than 50 rheumatoid arthritis (RA) investigators from across the U.S. recently met in Ft. Worth, Texas, to share information, present data and results from their innovative RA research projects, and brainstorm ways to work more closely together to find a cure for the disease.
REF’s Campaign to Support RA Research Nears its Initial Funding Target
The REF’s campaign to support RA research nears its initial funding target
The Key to Early Rheumatoid Arthritis
The conundrum of classification versus diagnosis
How to Provide Compassionate Care When Touch Is Painful
Providing compassionate care when touch is painful
Research Offers Hope of New Therapies to Prevent Bone Loss and Destruction
A study recently published in Annals of the Rheumatic Diseases shows promise for potential new therapies to prevent bone loss and bone destruction in patients with rheumatoid arthritis (RA).
- « Previous Page
- 1
- …
- 66
- 67
- 68
- 69
- 70
- …
- 75
- Next Page »